You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 28 No. 6, June 1973 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (10)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Low Doses of Dipropyltryptamine in Psychotherapy

Robert A. Soskin, PhD; Stainslav Grof, MD; William A. Richards, STM

Arch Gen Psychiatry. 1973;28(6):817-821.


Abstract

Dipropyltryptamine (DPT) is a hallucinogenic drug that has a shorter duration of action than lysergic acid diethylamide (LSD) and a relatively abrupt termination of activity. This study is an evaluation of the effectiveness of DPT compared to a placebo on a number of dimensions commonly regarded as significant in psychotherapy.

Eighteen alcoholic patients received a total of 72 DPT and 64 placebo therapy interviews on a double-blind basis. Doses of 15 to 30 mg of DPT were used, and the duration of the interviews was two hours. According to therapists' ratings, there was a significant enhancement in recall of memories and experiences, greater emotional expressiveness, deeper levels of self-exploration, and greater psychodynamic resolution in the DPT interviews. Patients also rated DPT sessions as more productive. These findings suggest that DPT might be a practical and useful adjunct to psychotherapy.



Author Affiliations

Baltimore

From the Maryland Psychiatric Research Center, Baltimore.


Footnotes

Accepted for publication Jan 13, 1973.

Reprint requests to Maryland Psychiatric Research Center, Box 3235, Baltimore, MD 21228 (Dr. Soskin).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hallucinogens on the Internet: A Vast New Source of Underground Drug Information
Halpern and Pope
Am. J. Psychiatry 2001;158:481-483.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1973 American Medical Association. All Rights Reserved.